Cognition Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CGTX and other ETFs, options, and stocks.

About CGTX

Cognition Therapeutics, Inc. is a clinical stage neuroscience company. The firm develops drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders. 

CEO
Lisa R. Ricciardi
CEOLisa R. Ricciardi
Employees
21
Employees21
Headquarters
Purchase, New York
HeadquartersPurchase, New York
Founded
2007
Founded2007
Employees
21
Employees21

CGTX Key Statistics

Market cap
38.61M
Market cap38.61M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
59.23K
Average volume59.23K
High today
$1.95
High today$1.95
Low today
$1.70
Low today$1.70
Open price
$1.75
Open price$1.75
Volume
47.98K
Volume47.98K
52 Week high
$13.80
52 Week high$13.80
52 Week low
$1.50
52 Week low$1.50

CGTX Earnings

-$11.74
-$7.83
-$3.91
$0.00
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 17, Pre-Market
ActualExpected Nov 17, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.